NCT00329030 2021-11-01BMTCTN0401National Heart, Lung, and Blood Institute (NHLBI)Phase 3 Completed224 enrolled 24 charts
NCT01789255 2018-07-24Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesNational Cancer Institute (NCI)Phase 2 Completed12 enrolled 11 charts
NCT00131937 2015-09-03Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Completed14 enrolled 7 charts
NCT00054639 2014-05-28Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Completed48 enrolled 5 charts
NCT00290472 2014-05-23CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Completed89 enrolled 9 charts